DNMT3A and capillary hemangioma: They also showed that overexpression of miR-206 in xenografted infant hemangioma endothelial cells inhibited DNMT3A activity and suppressed the development of infantile hemangioma in mice, suggesting the potential of miR-206 as a therapeutic agent (Figure 5) [152].